The multistep process of colon carcinogenesis

Cytokines and Molecular Therapy

Volumn 2, Issue 4, 1996, Pages 111-114

  Aaltonen, Lauri A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Colon cancer; Genetics; Hereditary; Tumorigenesis

Indexed keywords

ARTICLE; COLON CARCINOGENESIS; COLORECTAL TUMOR; GENE REPRESSION; HUMAN; MOLECULAR GENETICS; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; ONCOGENES;

EID: 0029845774     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Winaver SJ, Zauber AG, Ho MN et al, Prevention of colorectal cancer by colonoscopic polypectomy. N EnglJMed(l993) 329: 1977-81.
2. Järvinen HJ, Mecklin, J-P, Sistonen P, Screening reduces colorectal cancer rate in families with hereditary nonpolyposis colorectal cancer. Gastroenterology (1995) 108: 1405-11.
3. Groden J, Thliveris A, Samowitz W et al, Identification and characterization of the familial adenomatous polyposis coli gene. Cell (1991) 66: 589-600.
4. Kinzler KW, Nilbert MC, Su L-K et al, Identification of FAP locus genes from chromosome 5q21. Science (1991) 253: 661-5.
5. Nishisho I, Nakamura Y, Miyoshi et al, Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 253: 665-9.
6. Joslyn G, Carlson M, Thliveris A et al, Identification of deletion mutations and three new genes at the familial polyposis locus. Cell (1991) 66: 601-13.
7. Powell SM, Zilz N, Beazer-Barclay Y et al, APC mutations occur early during colorectal tumorigenesis. Nature (1992) 359: 235-7.
8. Peltomäki P, Aaltonen LA, Sistonen P et al, Genetic mapping of a locus predisposing to human colorectal cancer. Science (1993) 260: 810-12.
9. lonov Y, Peinado MA, Malkhosyan S et al, Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis. Nature (1993) 363: 558-61.
10. Aaltonen LA, Peltomäki P, Leach F et al, Clues to the pathogenesis of familial colorectal cancer. Science (1993) 260: 812-16.
11. Thibodeau SN, Bren G, Schaid D, Microsatellite instability in cancer of the proximal colon. Science (1993) 260: 816-19.
12. 2 and its association with hereditary nonpolyposis colorectal cancer. Cell (1993) 75: 1027-38.
13. Leach FS, Nicolaides NC, Papadopoulos N et al, Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell (1993) 75: 1215-25.
14. Papadopoulos N, Nicolaides NC, Wei Y-F et al, Mutation of a mutL homolog is associated with hereditary colon cancer. Science (1994) 263: 1625-9.
15. Bronner CE, Baker SM, Morrison PT et al, . Mutation in the DNA mismatch repair gene homologue hMLHl is associated with hereditary non-polyposis colon cancer. Nature (1994) 368: 258-61.
16. Nicolaides NC, Papadopoulos N, Liu B et al, Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (1994) 371: 75-80.
17. Malkin D, Li FP, Strong LC et al, Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science (1990) 250: 1233-8.
18. Srivastava S, Zou ZQ, Pirollo K et al, Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome. Nature (1990) 348: 747-9.
19. Hollstein M, Sidransky D, Vogelstein B, Harris CG, p53 mutations in human cancers. Science (1991) 253: 49-53.
20. Fearon ER, Cho KR, Nigro JM et al, Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 247: 49-56.
21. Bos JL, Fearon ER, Hamilton SR et al, Prevalence of ras gene mutations in human colorectal cancers. Nature (1987) 327: 293-7.
22. Forrester K, Almoguera C, Han K et al, Detection of high incidence of K-ras oncogenes during human colon tumorigenesis. Nature (1987) 327: 298-303.
23. Kallioniemi A, Kallioniemi O-P, Sudar D et al, Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (1992) 258: 818-21.
24. Vogelstein B, Fearon ER, Hamilton SR et al, Genetic alterations during colorectal tumor development. N EnglJMed(19SS) 319: 525-32.
25. Fearon ER, Vogelstein B, A genetic model for colorectal tumorigenesis. Cell (1990) 61: 759-67.
26. Boland CR, Sato J, Appelman HD et al, Microallelotyping defines the sequence and tempo of allelic losses at tumor suppressor gene loci during colorectal cancer progression. Nature Med (1995) 1: 902-9.
27. Kirn NW, Piatyszek MA, Prowse KR et al, Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 266: 2011-15.
28. Chadenau C, Hay K, Hirte HW et al, Telomerase activity associated with acquisition of malignancy in human colorectal cancer. Cancer Res (1995) 55: 2533-6.
29. Wang L, Patel U, Ghosh L et al, Mutation in thé nm23 gene is associated with metastasis in colorectal cancer. Cancer Res (1993) 53: 717-20.
30. Heide I, Thiede C, Poppe K et al, Expression and mutational analysis of Nm23-Hl in liver métastases of colorectal cancer. Br J Cancer (1994) 70: 1267-71.
31. 2 messenger RNA expression and absence of mutations in colon carcinomas of low and high metastatic potential. J Natl Cancer Inst (1993) 85: 147-52.
32. Laird PW, Jackson-Grusby, L, Fazeli A et al, Suppression of intestinal neoplasia by DNA hypomethylation. Cell (1995) 81: 197-205.
33. Bell SM, Scott N, Cross D et al, Prognostic value of p53 overexpression and c-Ki-ras gene mutations in -colorectal cancer. Gastroenterology (1993) 104: 57-64.
34. BR, Robbins P, Soong R et al, The common molecular genetic alterations in Dukes' B and C colorectal carcinomas are now short-term prognostic indicators of survival. Int J Cancer (1994) 59: 747-51.
35. Sidransky D, Tokino T, Hamilton SR et al, Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 1992) 256: 102-5.
36. Jen J, Kim H, Piantadosi S et al, Allelic loss of chromosome 18q and prognosis in colorectal cancer. NEnglJMed(1994) 331: 213-21.
37. Bosari S, Viale G, Bossi P et al, Cytoplasmic accumulation of p53 protein -an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer bist (1994) 86: 681-7.
38. Laurent-Puig P, Olschwang S, Delattre O et al, Survival and acquired genetic alterations in colorectal caner. Gastroenterology (1992) 102: 1136-41.
39. Powell SM, Petersen GM, Krush AJ et al, Molecular diagnosis of familial adenomatous polyposis. N EnglJ Afetf(1993) 329: 1982-7.
40. Lothe RA, Peltomäki P, Meling G-I et al, Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res (1993) 53: 5849-52.
41. Sankila R, Aaltonen LA, Järvinen HJ, Mecklin J-P, Better survival rates in MLH1-associated hereditary colorectal cancer. Gastroenterology (1996) 110: 682-7.
42. Aaltonen LA, Peltomäki P, Mecklin J-P et al, Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res (1994) 54: 1645-8.
43. Goyette MC, Cho K, Fashing CL et al, Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol Cell Biol (1992) 12: 1387-95.